Hartmann C - Search Results

1

Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.

Hartmann C, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, von Deimling A, Weller M; German Glioma Network. Hartmann C, et al. Clin Cancer Res. 2013 Sep 15;19(18):5146-57. doi: 10.1158/1078-0432.CCR-13-0017. Epub 2013 Aug 5. Clin Cancer Res. 2013. PMID: 23918605 Free article.

2

The rate of homozygous CDKN2A/p16 deletions in glioma cell lines and in primary tumors.

Hartmann C, Kluwe L, Lücke M, Westphal M. Hartmann C, et al. Int J Oncol. 1999 Nov;15(5):975-82. doi: 10.3892/ijo.15.5.975. Int J Oncol. 1999. PMID: 10536182

3

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.

Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J, Veelken J, Schramm J, Weller M, Wiestler OD, Louis DN, von Deimling A. Mueller W, et al. Among authors: hartmann c. Am J Pathol. 2002 Jul;161(1):313-9. doi: 10.1016/S0002-9440(10)64183-1. Am J Pathol. 2002. PMID: 12107116 Free PMC article.

4

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN. Nutt CL, et al. Among authors: hartmann c. Cancer Res. 2003 Apr 1;63(7):1602-7. Cancer Res. 2003. PMID: 12670911

5

No preferential loss of paternal 19q alleles in oligodendroglial tumors.

Hartmann C, Mueller W, Lass U, Stockhammer F, von Eckardstein K, Veelken J, Jeuken J, Wick W, von Deimling A. Hartmann C, et al. Ann Neurol. 2003 Aug;54(2):256-8. doi: 10.1002/ana.10649. Ann Neurol. 2003. PMID: 12891681

6

Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.

Hartmann C, Nümann A, Mueller W, Holtkamp N, Simon M, von Deimling A. Hartmann C, et al. Int J Cancer. 2004 Mar 1;108(6):839-44. doi: 10.1002/ijc.11638. Int J Cancer. 2004. PMID: 14712485

7

No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma.

Tallen G, Kaiser I, Krabbe S, Lass U, Hartmann C, Henze G, Riabowol K, von Deimling A. Tallen G, et al. Among authors: hartmann c. Int J Cancer. 2004 Apr 10;109(3):476-9. doi: 10.1002/ijc.11715. Int J Cancer. 2004. PMID: 14961591

8

Pathology and molecular genetics of oligodendroglial tumors.

Hartmann C, Mueller W, von Deimling A. Hartmann C, et al. J Mol Med (Berl). 2004 Oct;82(10):638-55. doi: 10.1007/s00109-004-0565-9. J Mol Med (Berl). 2004. PMID: 15322700 Review.

9

Pdgfr-alpha in 1p/19q LOH oligodendrogliomas.

Hartmann C, Xu X, Bartels G, Holtkamp N, Gonzales IA, Tallen G, von Deimling A. Hartmann C, et al. Int J Cancer. 2004 Dec 20;112(6):1081-2. doi: 10.1002/ijc.20525. Int J Cancer. 2004. PMID: 15386438 No abstract available.

10

Estimating cancer survival and clinical outcome based on genetic tumor progression scores.

Rahnenführer J, Beerenwinkel N, Schulz WA, Hartmann C, von Deimling A, Wullich B, Lengauer T. Rahnenführer J, et al. Among authors: hartmann c. Bioinformatics. 2005 May 15;21(10):2438-46. doi: 10.1093/bioinformatics/bti312. Epub 2005 Feb 10. Bioinformatics. 2005. PMID: 15705654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,117 results

Search Page

Filters